Radiation Oncology Quality Surveillance Program

Q701--Radiation Oncology Quality Surveillance (VHA-ROQS) Program (VA-26-00040021) Q701--Radiation Oncology Quality Surveillance (VHA-ROQS) Program (VA-26-00040021) Notice VETERANS AFFAIRS, DEPARTMENT OF VETERANS AFFAIRS, DEPARTMENT OF -NETWORK CONTRACT (36C245) Professional Organizations Page 1 of Page 4 of 4 Page 1 of 1 This intent to sole source announcement is posted in accordance with FAR 5.2Â - Synopses of Proposed Contract Actions.

Objective The Veterans Health Administration National Radiation Oncology Program (VHA NROP) seeks to sustain and enhance the Radiation Oncology Quality Surveillance (VHA ROQS) Program by maintaining an evidence based framework of Clinical Quality Measures (CQMs) and surveillance tools across VHA Radiation Oncology Services. The

objectives are to

• (a) evaluate and update CQMs for major disease sites (e.g., lung, prostate, breast, head & neck, GI) and disease agnostic technical components,
• (b) identify care gaps and variability in radiotherapy planning and delivery, and
• (c) support continuous quality improvement enterprise wide through standardized scoring logic and abstraction-ready data elements. The contemplated

period of performance is September 18, 2026 through September 17, 2031 (base + four option years) Unique Qualifications The only known source with the combination of capabilities required to meet VHA NROP s ROQS

objectives: Established VA programmatic history and methodology: the incumbent developer of VA s disease site CQMs and has collaborated with NROP through expert Blue Ribbon Panels to produce evidence based measures and scoring criteria already embedded in VA s surveillance workflows. Proprietary/validated CQM framework and SME access: maintains the convening power, expert networks, and validated logic decision trees necessary to define pass/fail/exclusion outcomes and abstraction-ready data elements applicable across all 41 VHA radiation oncology services (as referenced by NROP program materials). Market research found no equivalent organization able to develop, evaluate, and sustain radiation oncology specific CQMs at VA s scale. Follow on continuity and risk mitigation: the incumbent provides continuity of CQM definitions, scoring logic, and quality reports. Transitioning to a new source would disrupt ongoing surveillance, introduce methodological incompatibilities, and risk delays in updating CQMs aligned with current national guidelines. Market research efforts (GSA/SAM and outreach) did not identify alternate sources capable of meeting the requirement. Award information The incumbent contractor shall be provided with the opportunity to present a quote that shall be accepted as a firm fixed price agreement at the lowest price technically acceptable (LPTA). The Government anticipates the Independent Cost Estimate shall be developed and comparable with the current incumbent to justify fair and reasonable